pramipexole + rasagiline (Zhejiang Jingxin Pharmaceutical)

N/A

Report date: 2025/01/26 16:46:32
NME

Base Information

Drug Namepramipexole + rasagiline (Zhejiang Jingxin Pharmaceutical)
Drug Alias Name2169
ClassificationSmall molecules
Mechanisms of ActionDopamine D3 receptor agonistsMonoamine oxidase B inhibitors
TargetsMonoamine oxidase BDopamine D3 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Jingxin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Jingxin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A